Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Geranylgeranyltransferase I inhibitor for treatment of a PTEN defective cancer

Geranylgeranyltransferase I inhibitor for treatment of a PTEN defective cancer

US Patent 11583525 · Granted Feb 21, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aurora kinase and janus kinase inhibitors for prevention of graft versus host di2024
Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cyc2023
Mutant KRAS inhibitors2022
Aurora kinase and Janus kinase inhibitors for prevention of graft versus host di2021
STAT3 dimerization inhibitors2021
Methods for inducing tumor regression, inhibiting tumor growth, and inducing apo2021
Small molecules that mimic or antagonize actions of granulocyte colony-stimulati2020
Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cyc2020
Small molecule inhibitors of STAT3 with anti-tumor activity2020
Compositions including triciribine and epidermal growth factor receptor inhibito2020
Methods of treating breast cancer that overexpress AKT kinase2020
Mutant KRas inhibitors2020